Oncology Central

AACR 2018: highlights and the biggest news headlines

0
We have compiled the top headlines from the American Association for Cancer Research (AACR) Annual Meeting 2018 (April 14–18, IL, USA). Highlights include:
  • Positive data announced for KEYTRUDA® in adjuvant melanoma
  • KEYTRUDA scores big again in NSCLC Phase III KEYNOTE-189 study
  • Pembrolizumab and chemotherapy combo doubles survival in metastatic lung cancer
  • Promising immunotherapy strategy discovered for stage I–III NSCLC patients

KEYTRUDA scores big again in NSCLC Phase III KEYNOTE-189 study

Details of the KEYNOTE-189 study have been announced by Merck (known as MSD outside the United States and Canada).

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Articles

Interviews

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.